Züblin Immobilien Holding AG (LON:0REW)

Market Cap	169.79M
Revenue (ttm)	8.26M
Net Income (ttm)	7.60M
Shares Out	n/a
EPS (ttm)	2.29
PE Ratio	22.33
Forward PE	n/a
Dividend	0.88 (1.52%)
Ex-Dividend Date	Jul 1, 2024

Volume	754
Average Volume	136
Open	53.00
Previous Close	57.50
Day's Range	53.00 - 57.00
52-Week Range	25.00 - 60.00
Beta	0.15
RSI	66.75
Earnings Date	n/a

About Regulus Therapeutics

Züblin Immobilien Holding AG and its subsidiaries (together the Züblin Group) are focused on the management of the Group’s real estate portfolio. As of 31 March 2025, the Züblin Group is solely operational in Switzerland and has employed four persons (31 March 2024: four persons). Züblin Immobilien Holding AG is a Swiss stock corporation domiciled at Hardturmstrasse 76, Zurich, Switzerland, and is the parent company of the Züblin Group. The company’s shares are traded on the main segment of SIX Swiss Exchange.

• Industry: Real Estate Services
• Sector: Real Estate
• CEO: Philippe Brandle
• Employees: 4
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0REW

Financial Performance

In 2024, LON:0REW's revenue was 9.43 million, an increase of 4.33% compared to the previous year's 9.04 million. Earnings were 8.69 million, an increase of 549.10%.